Amgen Inc AMGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 4:04 PM EDT

311.41UNCH (UNCH)

Volume

65,713

311.41

+2.96 (+0.96%)

Volume

1,564,008

52 week range

211.71 - 329.72

Open308.73
Day High312.40
Day Low307.47
Prev Close308.45
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23

Key Stats

Market Cap167.051B
Shares Out536.43M
10 Day Average Volume3.47M
Dividend9.00
Dividend Yield2.89%
Beta0.60
YTD % Change8.12

KEY STATS

Open308.73
Day High312.40
Day Low307.47
Prev Close308.45
52 Week High329.72
52 Week High Date02/05/24
52 Week Low211.71
52 Week Low Date06/01/23
Market Cap167.051B
Shares Out536.43M
10 Day Average Volume3.47M
Dividend9.00
Dividend Yield2.89%
Beta0.60
YTD % Change8.12

RATIOS/PROFITABILITY

EPS (TTM)7.00
P/E (TTM)44.50
Fwd P/E (NTM)16.06
EBITDA (TTM)11.625B
ROE (TTM)72.57%
Revenue (TTM)29.532B
Gross Margin (TTM)66.38%
Net Margin (TTM)12.74%
Debt To Equity (MRQ)1,274.79%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date05/16/2024
Div Amount2.25
Split Date-
Split Factor-

Latest On Amgen Inc

Trade Tracker: Bill Baruch buys more Apple and AmgenMay 8, 2024CNBC.com
Dow pops more than 170 points to notch sixth positive day and longest win streak in 2024May 7, 2024CNBC.com
New rivals could threaten Novo Nordisk, Eli Lilly's weight loss drug dominance May 7, 2024CNBC.com
What's driving this multiday rally, plus Jim Cramer's quick takes on 4 stocksMay 6, 2024CNBC.com
Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or betterMay 6, 2024CNBC.com

Content From Our Affiliates

Dow Jones (DJIA) Dominates in May: Here’s Why the Trend Could ContinueMay 9, 2024TipRanks
Amgen price target raised to $235 from $223 at MizuhoMay 9, 2024TipRanks
Wedbush upgrades CytomX to Outperform on ‘encouraging’ CX-904 Phase 1a dataMay 9, 2024TipRanks
Drugmakers work to make treatments to maintain weight loss, WSJ reportsMay 8, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Teleflex (TFX) and Axsome Therapeutics (AXSM)May 8, 2024TipRanks

Profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin...

Robert Bradway

Chairman of the Board, President, Chief Executive Officer

Peter Griffith

Chief Financial Officer, Executive Vice President

David Reese

Executive Vice President, Chief Technology Officer

Murdo Gordon

Executive Vice President - Global Commercial Operations

Lori Johnston

Executive Vice President - Human Resources

Address

One Amgen Center Drive

Thousand Oaks, CA

91320

United States

https://www.amgen.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
PFE Pfizer Inc	28.38	-0.06	-0.21%
NVS Novartis AG	103.31	+1.05	+1.03%
SNY Sanofi SA	49.50	-0.71	-1.41%
GILD Gilead Sciences Inc	67.65	+0.11	+0.16%
RHHBY Roche Holding AG	30.95	+0.60	+1.98%